Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial
Journal of Neuroendocrinology · 2026-11 · 38 (11)
DOI: 10.1111/jne.70308 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 05.11.2026. Verfasst von Vera Reber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Prolactin, Glucagon-Like Peptides, Recombinant Fusion Proteins, Immunoglobulin Fc Fragments. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Gottfired & Julia Bangerter-Rhyner Stiftung, Goldschmidt-Jacobson Foundation.
Abstract (Originalsprache)
Prolactin (PRL) is involved in the modulation of sexual function. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have been proposed to modulate reward‐related processes beyond their effects on appetite, including sexual desire. In our previously published randomized parent trial of dulaglutide and sexual desire, we hypothesized that any potential effect on sexual desire could involve changes in PRL concentrations. Predefined secondary analysis of a single‐center randomized, double blind, placebo‐controlled, crossover trial involving 24 healthy eugonad men of normal weight (BMI 18.5–25 kg/m 2 or BMI 25.1–30 kg/m 2 and waist circumference
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
- Department of Clinical Research, University of Basel, Basel, Switzerland.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Vera Reber, Cyrill Denis Mueller, Laura Werlen, Bettina Winzeler
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Gottfired & Julia Bangerter-Rhyner Stiftung
- Goldschmidt-Jacobson Foundation
- Department of Internal Medicine of the University Hospital of Basel
- Schweizerische Akademie der Medizinischen Wissenschaften
Zitieren
APA
Reber, V., Mueller, C. D., Lengsfeld, S., Probst, L., Werlen, L., Allen, R., Emara, Y., Bathelt, C., & Winzeler, B. (2026). Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial. Journal of Neuroendocrinology, 38(11). https://doi.org/10.1111/jne.70308
Vancouver
Reber V, Mueller CD, Lengsfeld S, Probst L, Werlen L, Allen R, et al. Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial. Journal of Neuroendocrinology. 2026;38(11). doi:10.1111/jne.70308
BibTeX
@article{Reber2026,
author = {Reber, Vera and Mueller, Cyrill Denis and Lengsfeld, Sophia and Probst, Leila and Werlen, Laura and Allen, Richard and Emara, Yara and Bathelt, Cemile and Winzeler, Bettina},
title = {Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial},
journal = {Journal of Neuroendocrinology},
year = {2026},
volume = {38},
number = {11},
doi = {10.1111/jne.70308}
}
EUVIMED